![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
W Wargin, K Patrick, C Kilts, CT Gualtieri, K Ellington, RA Mueller, G Kraemer and GR Breese
The pharmacokinetics and bioavailability of methylphenidate (MPH) and a metabolite, ritalinic acid (RA), were studied in normal adults, children with hyperactivity, monkeys and rats. Adult males received 0.15 or 0.3 mg/kg of MPH orally and MPH and RA were analyzed in plasma samples obtained at various times after treatment. Maximal MPH concentrations in plasma were found to occur 2.2 hr after administration of either dose (range: 1.0-4.0). The mean (+/-S.E.) maximal concentration in plasma for MPH was 3.5 +/- 0.4 ng/ml after 0.15 mg/kg and 7.8 +/- 0.8 ng/ml after 0.3 mg/kg. MPH clearances were high (10.1 liters/hr/kg) and variable (range: 3.6-23.2) for the 0.3 mg/kg dose. Pharmacokinetic parameters for children receiving 0.3 mg/kg were essentially the same as for adults. RA plasma levels were 50 to 100 times greater than MPH levels in normal adults. The clearance of RA is less than that of MPH. The absolute bioavailability of MPH was found to be 0.19 in the rat and 0.22 in the monkey, suggesting substantial presystemic elimination of MPH.
This article has been cited by other articles:
|
|
 |
|
  J. D. Gray, M. Punsoni, N. E. Tabori, J. T. Melton, V. Fanslow, M. J. Ward, B. Zupan, D. Menzer, J. Rice, C. T. Drake, et al. Methylphenidate Administration to Juvenile Rats Alters Brain Areas Involved in Cognition, Motivated Behaviors, Appetite, and Stress J. Neurosci., July 4, 2007; 27(27): 7196 - 7207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Devilbiss and C. W. Berridge Low-Dose Methylphenidate Actions on Tonic and Phasic Locus Coeruleus Discharge J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1327 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Swanson, S. B. Wigal, T. Wigal, E. Sonuga-Barke, L. L. Greenhill, J. Biederman, S. Kollins, A. S. Nguyen, H. H. DeCory, S. J. Hirshe Dirksen, et al. A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study) Pediatrics, March 1, 2004; 113(3): e206 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kuczenski and D. S. Segal Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine J. Neurosci., August 15, 2002; 22(16): 7264 - 7271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J Le Nedelec and R J Rosengren Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse Human and Experimental Toxicology, May 1, 2002; 21(5): 273 - 280. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Rozans, A. Dreisbach, J. J.L. Lertora, and M. J. Kahn Palliative Uses of Methylphenidate in Patients With Cancer: A Review J. Clin. Oncol., January 1, 2002; 20(1): 335 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kuczenski and D. S. Segal Locomotor Effects of Acute and Repeated Threshold Doses of Amphetamine and Methylphenidate: Relative Roles of Dopamine and Norepinephrine J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 876 - 883. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Gerasimov, M. Franceschi, N. D. Volkow, A. Gifford, S. J. Gatley, D. Marsteller, P. E. Molina, and S. L. Dewey Comparison between Intraperitoneal and Oral Methylphenidate Administration: A Microdialysis and Locomotor Activity Study J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 51 - 57. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. S. Markowitz, C. L. DeVane, D. W. Boulton, Z. Nahas, S. C. Risch, F. Diamond, and K. S. Patrick Ethylphenidate Formation in Human Subjects after the Administration of a Single Dose of Methylphenidate and Ethanol Drug Metab. Dispos., June 1, 2000; 28(6): 620 - 624. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. D. Volkow, Gene.-J. Wang, J. S. Fowler, S. J. Gatley, J. Logan, Y.-S. Ding, R. Hitzemann, and N. Pappas Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral Methylphenidate Am J Psychiatry, October 1, 1998; 155(10): 1325 - 1331. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
